Win-X hyperphobic coatings for self-cleaning applications
Win-X hyperphobic coatings offer a fluorine-free, cost-effective solution for liquid and solid repellency, ideal for self-cleaning surfaces like toilet bowls. These coatings hold promise as an alternative to PFOS chemicals, with a focus on developing room temperature curing catalysts.
Overview
Win-X hyperphobic coatings are an innovative solution designed to resist both liquids and solids without the use of fluorine, making them an environmentally friendly alternative to PFOS "forever chemicals." These coatings are made from economical materials and are particularly suited for applications requiring self-cleaning properties, such as toilet bowls and other surfaces. With water drop sliding at tilt angles of less than 10 degrees, these coatings demonstrate remarkable hydrophobicity.
Technical specifications
Key features:
- Fluorine-free composition: Avoids environmental and health concerns associated with PFOS chemicals.
- Low adhesion properties: Effective against liquids like water and oils, and solids such as epoxy and ice.
- Economical and simple preparation: Developed in one step from cost-effective materials.
- Hydrophobic and oleophobic: Proven through X-ray photoelectron spectroscopy analysis.
Technical challenges:
- High cure temperature: Currently requires over 150°C, necessitating the development of a catalyst for room temperature curing to expand household applications.
Technology readiness level
Currently at Technology Readiness Level 3, the Win-X coating technology has demonstrated proof of concept and basic functionality. Further research is required to develop a catalyst for ambient temperature curing, which would broaden its application scope to household use.
About WynnVision LLC
WynnVision LLC is a biomedical company founded in 2016 that specializes in developing rapid, surface-modifying technologies for medical devices. By altering surface chemistry, their proprietary approach aims to kill bacteria on contact and inhibit biofilm formation, addressing significant healthcare challenges such as ventilator-associated pneumonia and catheter-related infections. The company provides a range of research services, including surface characterization, antimicrobial efficacy testing, and biocompatibility assessments, utilizing state-of-the-art equipment to perform evaluations consistent with ASTM guidelines.
These capabilities support the healthcare sector by providing innovative strategies to enhance patient safety and device longevity, specifically targeting infections that are difficult to diagnose and treat. Supported by multiple research grants from the National Institutes of Health and various innovation partnerships, WynnVision focuses on translating scientific research into practical, therapeutic solutions. Their work is central to reducing device-related complications, with ongoing projects aimed at improving the performance of indwelling catheters, endotracheal tubes, and surgical shunts.
delivered to your inbox.